Noa Therapeutics Analysis: $2M Raised
What is Noa Therapeutics?
Restores innate immune homeostasis in inflammatory diseases
HQ Country
Toronto, Canada
Employees
11-50
Founded
2022
HQ State/Province
Ontario
Funding Category
Seed
HQ Full Address
Toronto, Ontario, Canada
Product Features & Capabilities
- Proprietary small molecules targeting non-canonical AhR signaling
- NOA-104 in IND enabling studies for atopic dermatitis
- Oral NCEs in early in vitro proof of concept for gastrointestinal indications
Other Considerations
Secured pre-seed financing in 2024; Awarded National Eczema Association grant to Johns Hopkins University for research validation; Advancing NOA-104 with best-in-class preclinical efficacy data
